Page last updated: 2024-12-06

telmesteine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

telmesteine: RN refers to (-R)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65946
CHEMBL ID2107621
CHEBI ID134866
SCHEMBL ID637246
MeSH IDM0241640

Synonyms (27)

Synonym
telmesteine
CHEBI:134866
(4r)-3-ethoxycarbonyl-1,3-thiazolidine-4-carboxylic acid
telmesteine (inn)
D08565
122946-43-4
reolase (tn)
telmesteina
telmesteina [inn-spanish]
124i3fe35t ,
unii-124i3fe35t
(-)-3-ethyl hydrogen (r)-3,4-thiazolidinedicarboxylate
telmesteinum [inn-latin]
telmesteine [inn]
telmesteinum
AKOS010385372
CHEMBL2107621
reolase
telmesteine [who-dd]
telmesteine [inci]
telmesteine [mart.]
SCHEMBL637246
(r)-3-(ethoxycarbonyl)thiazolidine-4-carboxylic acid
DTXSID60153804
3,4-thiazolidinedicarboxylic acid, 3-ethyl ester, (4r)-
Q27251366
EN300-881275

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Only 2 patients discontinued MAS063DP due to an adverse event."( A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults.
Abramovits, W; Boguniewicz, M, 2006
)
0.33
"MAS063DP cream was confirmed to be a safe and effective treatment for mild to moderate atopic dermatitis in adults."( A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults.
Abramovits, W; Boguniewicz, M, 2006
)
0.33

Bioavailability

ExcerptReferenceRelevance
" (14)C-telmesteine was rapidly absorbed after oral dosing (20 and 50 mg kg(-1)) with an oral bioavailability of >90% both in male and female rats."( Absorption, distribution, metabolism and excretion of telmesteine, a mucolitic agent, in rat.
Kim, DH; Lee, J; Rhee, SW; Son, J, 2003
)
1.02

Dosage Studied

ExcerptRelevanceReference
" (14)C-telmesteine was rapidly absorbed after oral dosing (20 and 50 mg kg(-1)) with an oral bioavailability of >90% both in male and female rats."( Absorption, distribution, metabolism and excretion of telmesteine, a mucolitic agent, in rat.
Kim, DH; Lee, J; Rhee, SW; Son, J, 2003
)
1.02
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
organonitrogen compoundAny heteroorganic entity containing at least one carbon-nitrogen bond.
organooxygen compoundAn organochalcogen compound containing at least one carbon-oxygen bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.05 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (71.43%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other2 (28.57%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]